Paragon Biosciences LLC
Venture studioChicago Β· SeedβSeries A Β· 1 people tracked
Investment thesis
Paragon Biosciences operates as a company creator, combining best practices of established organizations with a portfolio approach to advanced science. It launches new companies built around cutting-edge scientific breakthroughs, supporting them with in-house capabilities across clinical development, regulatory affairs, manufacturing, and commercialization. Its focus centers on life sciences and biotechnology, aiming to translate emerging science into commercial-stage businesses.
Source: firm website, verified Aug 3, 2026.
Team Β· 1 people
from the firm's website
What they invest in
from 6 of 6 portfolio companiesBiotech Γ6Medical Devices Γ4Deep Tech Γ3Healthtech Γ2AI & Machine Learning Γ1Digital Health Γ1
HQs:United StatesΓ3
Investments Β· 6 tracked
founders shown can be your intro pathBy year:2023 Β· 12022 Β· 12 dated
Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases.
BiotechHealthtechMedical DevicesNorthbrook, US
Jeffrey Aronin(Director)inJeffrey M. Dayno, M.D.(President and Chief Executive Officer)inPatrick Morris(Secretary and Treasurer)inRobert Repella(Director and Chief Executive Officer)Darien Parhad(Chief Financial Officer)
BoardAaron Royston(Director)in
Co-investorsAisling CapitalValor Equity PartnersvenBio PartnersVivo Capital
CiRC Biosciences develops cellular reprogramming therapies that convert fibroblasts directly into specific neurons and cell types lost in degenerative eye and brain diseases.
BiotechDeep TechMedical Devices
Co-investorsPortal Innovations
Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, with a lead investigational asset, ecopipam, a selective dopamine D1 receptor antagonist for pediatric Tourette syndrome.
BiotechDigital Health
Co-investorsValor Equity Partners
Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, including ecopipam, an investigational dopamine D1 receptor antagonist for pediatric Tourette syndrome.
BiotechMedical Devices
Co-investorsBain Capital Life Sciences
Evozyne designs and builds engineered protein therapeutics using an AI-native platform, focusing on treatments for immune-mediated diseases.
AI & Machine LearningBiotechDeep TechHealthtechChicago, US
Aris Theologis(Executive Officer, Director)inDarien Parhad(Executive Officer)Patrick J. Morris(Executive Officer, Director)Marc Yoskowitz(CEO)inRama Ranganathan(Executive Officer, Director)
BoardJeffrey S. Aronin(Director)
Co-investorsOrbiMedFidelity InvestmentsNVenturesNVIDIAValor Equity Partners
Castle Creek Biosciences develops re-dosable gene therapies for genetic diseases, with a lead candidate (D-Fi) in registrational clinical trials for dystrophic epidermolysis bullosa.
BiotechDeep TechMedical DevicesExton, US
Matthew Gantz(President and Chief Executive Officer)inDavid ChuinMichael TownsleyChristopher J. LarsoninRhea WilliamsinJude Sullivan(Executive Officer)
Co-investorsValor Equity PartnersFidelity InvestmentsHorizon
Exits Β· 1
IPOs and acquisitions across the tracked portfolioHarmony BiosciencesNASDAQ: HRMY
Portfolio news
latest coverage across their companiesHarmony Biosciences Β· investing.com Β· Jul 17, 2026
Frequently asked questions
- How many investments has Paragon Biosciences LLC made?
- Paragon Biosciences LLC has 5 tracked investments.
- What stage does Paragon Biosciences LLC invest at?
- Paragon Biosciences LLC invests at the Seed, Series A stages.
- What sectors does Paragon Biosciences LLC focus on?
- Paragon Biosciences LLC focuses on Biotech, Healthtech, Longevity.
- Where is Paragon Biosciences LLC located?
- Paragon Biosciences LLC is headquartered in Chicago, US.
- Who does Paragon Biosciences LLC co-invest with?
- Paragon Biosciences LLC most often shares deals with Valor Equity Partners, Aisling Capital, OrbiMed, among 6 tracked co-investors.
Media Β· Podcasts & interviews
from their channelJeffrey Dayno, MD, Highlights Harmony Biosciences' Commitment to Patients, Passion and Purpose
Paragon Biosciences
How Paragon is Leading the Bio-Revolution
Paragon Biosciences
CiRC Biosciences--Advancing Vision Restoration Cell Therapy
Paragon Biosciences
Jeff Aronin Discusses the Acceleration of Life Science Innovation at Paragon Biosciences
Paragon Biosciences
Images
Similar investors
Flagship Pioneering is a firm that creates and builds companies to pioneer breakthroughs in science and technology for people and the planet, active for over 25 years.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.